# Moleculin Biotech Announces 1-for-20 Reverse Stock Split Effective Oct. 20

- URL: https://stocks.freetheai.org/news/moleculin-biotech-announces-1-for-20-reverse-stock-split-effective-oct-20-59c5e5
- Published: 2026-10-16T13:20:00Z
- Category: company_news; sentiment: bearish; impact: medium
- Symbols: [NASDAQ:MBRX](https://stocks.freetheai.org/symbols/NASDAQ-MBRX)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Moleculin Biotech, Inc. (MBRX) will carry out a 1-for-20 reverse stock split on Oct. 20, 2026. The stock was down 9.95% to $0.3701 following the announcement.

The split will lower the company's outstanding share count from roughly 20.9 million to approximately 1.05 million shares. Fractional shares will not be issued, and eligible stockholders will receive cash payments instead. Meanwhile, authorized common shares will remain unchanged at 500 million.

Trading under the post-split share structure will coincide with a new CUSIP identifier, 60855D 507. Investors will monitor how the reduced share count affects overall float and daily trading activity.

## Key points

- Moleculin Biotech, Inc. (MBRX) will execute a 1-for-20 reverse stock split on Oct. 20, 2026.
- Outstanding common shares will decrease from about 20.9 million to approximately 1.05 million.
- No fractional shares will be issued, with stockholders receiving cash in lieu of partial shares.
- Authorized common shares remain unchanged at 500 million under a new CUSIP number of 60855D 507.
- Shares of Moleculin Biotech dropped 9.95% to $0.3701 in recent trading.

## Questions and answers

### When does the Moleculin Biotech reverse stock split take effect?

The 1-for-20 reverse stock split takes effect on Oct. 20, 2026.

### How will the reverse split impact Moleculin Biotech share count?

The move reduces outstanding shares from approximately 20.9 million to roughly 1.05 million, while authorized shares remain at 500 million.

### What happens to fractional shares in the Moleculin Biotech split?

No fractional shares will be distributed. Stockholders entitled to fractional shares will receive cash payments instead.